2-异亚丙基-5,5-二甲基-1,3-环己二酮 | 122772-35-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: 2-异亚丙基-5,5-二甲基-1,3-环己二酮
• 英文名称: 2-Isopropylidene-5,5-dimethylcyclohexane-1,3-dione
• 英文别名: 5,5-Dimethyl-2-(propan-2-ylidene)cyclohexane-1,3-dione；5,5-dimethyl-2-propan-2-ylidenecyclohexane-1,3-dione
• CAS: 122772-35-4
• 化学式: C₁₁H₁₆O₂
• mdl: MFCD07369086
• 分子量: 180.247
• InChiKey: ZDFKYRBMJLTZCZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.636
• 拓扑面积：
  34.1
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2914299000

反应信息

• 作为产物：
  描述：

  4,4,7,7-tetramethyl-4,6,7,8-tetrahydro-2H-1-benzopyran-2,5(3H)-dione 生成 2-异亚丙基-5,5-二甲基-1,3-环己二酮
  参考文献：
  名称：

  HOBEL, KLAUS;MARGARETHA, PAUL, HELV. CHIM. ACTA, 72,(1989) N, C. 975-979

  摘要：

  DOI：

文献信息

• 2,3-DIPHENYL-VALERONITRILE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS
  申请人：Mosrin Marc

  公开号：US20140235446A1

  公开（公告）日：2014-08-21

  The compounds of the formula (I) in which L represents a radical of the formula and A 1 , B 1 and A 2 and B 2 are as defined in Claim 1, are suitable as herbicides for the control of harmful plants or as plant growth regulators. The compounds can be prepared by the process of Claim 12.

  式(I)中L代表式的基团，A1、B1、A2和B2如权利要求1所定义，适用于作为除草剂用于控制有害植物或作为植物生长调节剂。这些化合物可以通过权利要求12所述的方法制备。
• METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND
  申请人：Motoki Masuji

  公开号：US20090240067A1

  公开（公告）日：2009-09-24

  A method of producing a compound represented by formula (1), including: allowing 1,4-benzoquinone or 1,2-benzoquinone to react with a dithiocarbamate compound represented by formula (2) in a polar solvent: wherein R 1 and R 2 each independently represent a hydrogen atom, an alkyl group, an aryl group or a heterocyclic group, R 1 and R 2 may be the same or different and may be combined with each other to form a ring, X represents an ion necessary to neutralize the charge of the molecule, m represents an integer of 1 to 2, n represents an integer of 1 to 2, M represents a hydrogen atom, a metal atom or a conjugate acid of a base, p represents an integer of 1 to 4, and q represents an integer of 1 to 4.

  一种生产由化学式（1）表示的化合物的方法，包括：允许1,4-苯醌或1,2-苯醌在极性溶剂中与由化学式（2）表示的二硫代氨基甲酸盐化合物发生反应：其中R1和R2各自独立地表示氢原子、烷基、芳基或杂环基，R1和R2可以相同也可以不同，并且可以结合在一起形成环，X表示中性化分子电荷所需的离子，m表示1至2的整数，n表示1至2的整数，M表示氢原子、金属原子或碱的共轭酸，p表示1至4的整数，q表示1至4的整数。
• [EN] CONJUGATES UNDERGOING INTRAMOLECULAR REARRANGEMENTS<br/>[FR] CONJUGUÉS SUBISSANT DES RÉARRANGEMENTS INTRAMOLÉCULAIRES
  申请人：ASCENDIS PHARMA AS

  公开号：WO2021136808A1

  公开（公告）日：2021-07-08

  The present invention relates to conjugates and pharmaceutically acceptable salts thereof, reagents, intermediates, methods for the synthesis of said conjugates, pharmaceutical compositions comprising said conjugates and the use of said conjugates.

  本发明涉及共轭物及其药用可接受盐、试剂、中间体、合成上述共轭物的方法、包含该共轭物的制药组合物和使用该共轭物的方法。
• Process for preparing pentanoic diacid derivatives
  申请人：Ratiopharm GmbH

  公开号：EP2223909A1

  公开（公告）日：2010-09-01

  The present invention relates to a process for preparing pentanoic diacid derivatives useful for preparing pyrimidine derivatives, in particular as intermediates useful for preparing pyrimidine derivatives of a class that is effective at inhibiting the biosynthesis of cholesterol in humans, such as HMG-CoA reductase inhibitors, e.g. rosuvastatin.

  本发明涉及一种制备戊二酸衍生物的工艺，该衍生物可用于制备嘧啶衍生物，特别是用作制备有效抑制人体胆固醇生物合成的一类嘧啶衍生物（如 HMG-CoA 还原酶抑制剂，如罗伐他汀等）的中间体。
• GLUCAGON-LIKE PEPTIDE-1 ANALOGUE AND USE THEREOF
  申请人：Zhejiang Beta Pharma Inc.

  公开号：EP2565205A1

  公开（公告）日：2013-03-06

  Provided is a glucagon-like peptide-1 (GLP-1) analogue shown as the following formula, wherein X is selected from glycine and glycinamide. The GLP-1 analogue has a non-proteogenic amino acid residue in position 8 relative to the sequence GLP-1, and is acylated with a moiety comprising two acidic groups to the lysine residue in position 26. The GLP-1 analogue is resistant to dipeptidyl peptidase IV so as to have an extended half-life in vivo. Also provided is a use of the GLP-1 analogue in conquering blood sugar.

  本发明提供了一种胰高血糖素样肽-1（GLP-1）类似物，如下式所示，其中 X 选自甘氨酸和甘氨酰胺。相对于 GLP-1 序列，GLP-1 类似物在第 8 位有一个非蛋白源性氨基酸残基，并在第 26 位的赖氨酸残基上酰化了一个包含两个酸性基团的分子。GLP-1 类似物对二肽基肽酶 IV 具有抗性，从而延长了其在体内的半衰期。此外，还提供了 GLP-1 类似物在控制血糖方面的用途。